(35) reported that the transcription factor USF1 activates HAS2-AS1 transcription by recognizing and binding the lncRNA HAS2-AS1 promoter region, resulting in increased invasion and migration of glioma cells. The gene discussed is USF1; the disease is central nervous system cancer.